These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Author: Kober G, Veidt J, Mikludy R, Kaltenbach M.
    Journal: Arzneimittelforschung; 1983; 33(2a):313-7. PubMed ID: 6682323.
    Abstract:
    1. The dose-response relation and duration of action of the beta-blocking agent 5-(3-tert-butylamino-2-hydroxy-propoxy)-3,4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) were investigated by means of exercise testing under randomized, double-blind conditions in two groups of healthy probands (n = 9 and n = 9, respectively). 2. The effect of 2 mg carteolol p.o. on changes in heart rate, ischemic ST-segment depression, and blood pressure was studied in 10 patients with coronary heart disease using an exercise test performed 2 h after ingestion of the drug. 3. In terms of exercise heart rate, a clear dose-response relation was demonstrated over the range of dosages (1 and 5 mg) employed. Exercise heart rate was reduced by 10% after a single dose of approximately 0.5 mg. The beta-blocking effect of 0.2 mg carteolol, however, remains unconfirmed. A dosage increase from 5 to 25 mg yields only a slight additional effect. The therapeutically attainable maximal reduction in the rise in exercise heart rate should be about 20%. 4. 24 h after a single dose of carteolol, 60-90% of the initial drug effect was still evident. 5. Resting and standing heart rate were not influenced significantly by 1, 2, 5 or 25 mg carteolol. The groups displayed a somewhat variable response. 6. 2 h after intake of 2 mg carteolol, mean ischemic ST-segment depression was reduced by somewhat more than 50%. Blood pressure at rest remained unchanged, whereas the rise in systolic blood pressure during exercise was lowered significantly. 7. In comparison with other beta-blocking agents, carteolol was effective at low dosage levels and retained considerable potency 24 h after ingestion. In many cases, once--daily administration should be adequate to yield a satisfactory clinical response.
    [Abstract] [Full Text] [Related] [New Search]